Top Banner
Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1
85

Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Dec 14, 2015

Download

Documents

Will Costen
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Thomas E. Freese, PhDSherry Larkins, PhD

UCLA Integrated Substance Abuse ProgramsPacific Southwest Addiction Technology Transfer Center

1

Page 2: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The County of Los Angeles Department of Mental Health has collaborated with the Department of Health Services (DHS) to implement the following programs in an effort toward integration:The LACDMH/DHS Collaboration ProgramHealthy Way L.A. Community PartnersProject 50MHSA Innovation ProgramsCenter for Community Health of Downtown Los AngelesLACDMH & HealthCare Partners Collaborative Care Program

Page 3: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The LACDMH/DHS Collaboration ProgramDMH has co-located small teams comprised of social workers, marriage and family counselors, and medical case workers, in DHS Comprehensive Health Centers (CHC) and Multiservice Ambulatory Care Clinics (MACC) on a full-time basis. The DMH teams deliver short-term, early intervention, evidenced-based, specialty mental health services using the Mental Health Integration Program (MHIP) model to treat persons with mild to moderate mental health symptoms. MHIP is a stepped collaborative care model shown effective in treating persons with depression and anxiety seen in primary care settings. Clinical consultation with a psychiatrist is available to both the treatment teams and to the primary care providers.

3

Page 4: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Healthy Way L.A. Community PartnersDMH has partnered with numerous health care agencies under contract with the DHS, known as Community Partners (CP), to provide short-term, early intervention, evidence-based, specialty mental health services on-site at the CP agencies. CPs, many of which are also Federally Qualified Health Centers (FQHC), are providing services using the MHIP model. DMH has and continues to provide training on the MHIP model to clinical staff employed by the CPs who are providing services to individuals with mild to moderate mental health symptoms. Furthermore, partnerships have been established between the CPs and existing DMH directly-operated and contracted specialty mental health clinics to provide a well-coordinated referral process between health and mental health when a consumer requires a level of care beyond a short-term early intervention.

4

Page 5: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Project 50Project 50 is a demonstration program to identify, engage, house and provide integrated supportive services to the 50 most vulnerable, long-term chronically homeless adults living on the streets of Skid Row. The Los Angeles County Board of Supervisors passed the motion to implement Project 50 in November 2007.

Project 50 involves three phases: 1. Registry Creation2. Outreach Team3. Integrated Supportive Services Team.

Currently, Project 50 is operating in the third phase. Four Project 50 Replication sites have been developed in Santa Monica, Van Nuys, Venice and Hollywood. They are at various stages of implementation.

5

Page 6: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

MHSA Innovation ProgramsDMH community stakeholders have identified four (4) models of care that integrate mental health, physical health and substance abuse services. MHSA Innovation (INN) model programs seek to learn which practices increase quality of services, improve consumer outcomes, promote community collaboration and the most cost effective in order to meet the spectrum of needs of individuals who are uninsured/ economically disadvantaged, homeless and members of underrepresented ethnic populations. By implementation and evaluation of new and innovative approaches, the time-limited MHSA INN model programs will contribute to learning and inform future practice. The four Innovation Models include:◦ Integrated Clinic Model (ICM)◦ Integrated Mobile Health Team Model (IMHT)◦ Community-Designed Integrated Service Management Model

(ISM)◦ Integrated Peer Run Models-Peer Run Integrated Service

Management (PRISM) & Peer Run Respite Care Homes (PRRCH)

6

Page 7: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Center for Community Health of Downtown Los AngelesLed by the Los Angeles County Chief Executive Office (CEO), the Center for Community Health of Downtown Los Angeles (CCHDLA) is a private/public partnership that employs a one-stop shop of resources approach for homeless and low-income people in the Skid Row area of downtown Los Angeles. Opened in 2009, it has increased access to all health-related services, including primary health care, specialty care, mental health, substance abuse, optometry, dentistry, medication, x-rays, HIV education and prevention, and STD and TB clinics. Known as an “Integrated Care for the Homeless Model,” CCHDLA employs an Integrated Services Team approach in which all partner agencies involved in the consumer’s care confer and develop a comprehensive, integrated treatment plan and service delivery.

7

Page 8: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

LACDMH & HealthCare Partners Collaborative Care ProgramDMH has developed an integrated pilot program with HealthCare Partners (HCP) and LA Care Health Plan to treat chronically and persistently mentally ill (CPMI) patients through collaborative care. Dually-eligible (Medicare/Medi-Cal) individuals who enroll in an LA Care Medicare Advantage program will be primarily treated in HCP's Collaborative Care Centers, though they could also receive their care at home, in long-term care facilities and elsewhere depending on the individual needs of the patient. The patient's treatment plan is co-managed by a medical doctor and a psychiatrist along with a team of nurse practitioners, care managers, social workers, and psychologists. The patient’s medical care is fully integrated with behavioral health interventions that include pharmacologic and behavioral/social skills. It is anticipated that diagnoses included in this treatment model will predominately include: schizophrenia, bi-polar and obsessive-compulsive disorders, severe major depression with and without psychotic features, severe chemical dependency and dementia.

8

Page 9: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

These projects represent a dramatic shift toward a whole health orientation. This means that we all need to think about the work that we do as part of a wholistic system, rather than a separate entity.

This new orientation leads to the need for mental health staff to fulfill new roles in all DMH settings that ensure that services are provide in an integrated way. This will:◦ Increase treatment efficacy◦ Improve client outcomes◦ Increase staff satisfaction and

decrease burnout

See Handout for a full

description of each project

Page 10: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Primary care culture and effective communication

Role definitions for Mental Health staff in primary care settings

Medical issues that commonly co-occur with mental health and substance use

Barriers to service access A case example.

10

Page 11: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Average spending on healthper capita ($US PPP)

Total health expenditures aspercent of GDP

Notes: PPP = purchasing power parity; GDP = gross domestic product.Source: Commonwealth Fund, based on OECD Health Data 2012.

11

Page 12: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Source: Agency for Healthcare Research and Quality analysis of 2009 Medical Expenditure Panel Survey.

Distribution of health expenditures for the U.S. population, by magnitude of expenditure, 2009

1%5%

10%

50%

65%

22%

50%

97%

$90,061

$40,682

$26,767

$7,978

Annual mean expenditure

Page 13: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

In the USA and Canada, mental health disorders account for 25% of all years of life lost to disability and premature mortality1

One in four American adults experience a mental health disorder in a given year, and 1 in 17 have a seriously debilitating mental illness2

Among those who die by suicide, more than 90% have a diagnosable disorder4. In 2008, suicide was the tenth leading cause of

death in the USA6.

13

1. World Health Organization. (2004). The world health report 2004: changing history. Annex Table 3. A126-A127. Geneva: WHO.

2. Kessler RC, et al. (2005). Archives of General Psychiatry, 62: 617-627.

3. US Department of Health and Human Services. (1999). Mental health: a report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, 1999.

4. Minino AM, et al. (2011). Final Data for 2008. National Vital Statistics Reports 2011; 59(10): 01-127. Available: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59_10.pdf.

Page 14: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Mental health and substance use services are integral to health care services. The goals of DMH initiatives are:◦ Ensure positive experiences of care ◦ Enhance customer services

Ensure care is effective◦ Develop bi-directional care/behavioral health homes◦ Implement data outcomes system to enable

monitoring of client progress Control/reduce costs

◦ Develop strategies to extend care◦ Develop strategies to reduce readmission and

preventable hospitalizations14

Page 15: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Primary Care The aims of primary care are to provide

broad spectrum of care◦ both preventive and curative;◦ over a period of time; and ◦ to coordinate all of the care the patient receives.

All family physicians and most pediatricians and internists are in primary care.

◦ www.medicinenet.com

15

Page 16: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Primary Care Practitioner must possess a wide breadth of

knowledge in many areas. Patients consult the same primary care doctor

for routine check-ups, and initial consultation about a new complaint.

Common chronic illnesses, often treated in primary care, include:◦ Hypertension -- Diabetes◦ Asthma and COPD -- Depression and anxiety◦ Arthritis and other pain

16

Page 17: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

1. The person receiving services is called…2. The building(s)/place(s) where the person

receives services is called…3. The room where the person receives

services is called…4. The person who has the ultimate

responsibility for the care of the person is called…

5. The person who is responsible for care coordination is called…

17

Page 18: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

18

Page 19: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

19

Page 20: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

Learn about the medical conditions that bring people to primary care

20

Page 21: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

Learn about the medical conditions that bring people to primary care

Expand your vocabulary to facilitate communication

21

Page 22: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

Learn about the medical conditions that bring people to primary care

Expand your vocabulary to facilitate communication

Stay within your scope of practice in your interactions

22

Page 23: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

Learn about the medical conditions that bring people to primary care

Expand your vocabulary to facilitate communication

Stay within your scope of practice in your interactions

Make yourself visible and useful

23

Page 24: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

It is important to understand the system with which you are working

Learn about the medical conditions that bring people to primary care

Expand your vocabulary to facilitate communication

Stay within your scope of practice in your interactions

Make yourself visible and useful Be accessible and available

Page 25: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Who does what in an integrated care system?

25

Page 26: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

In an integrated care system, what is the best role of each of the following disciplines. What should they take lead on? How should they be involved in collaboration?Medical ProviderMental Health ProviderSubstance Use Disorder ProviderBehavioral Health SpecialistPeer SpecialistFamily

26

Page 27: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Differing practice styles

Differing practice cultures and language

Difficulty in matching provider skills with patient needs

Heavy reliance on physician services

Tension between direct patient care services (reimbursable) and integrative (non-reimbursable) services

27 27

Page 28: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Lack of recognition of provider limitations Lack of MH knowledge in PC providers and lack

of health knowledge in BH providers Lack of clinical competence in integrated service

models (MH/SU and BH/PC) and selection of proper integration model based on practice context

Differing confidentiality and information sharing procedures

Differing coding and billing systems Provider resistance

28

Page 29: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

From Co-Location to Fully Integrated From Co-Location to Fully Integrated CareCare

Bill RosenfeldBill Rosenfeld29

Page 30: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Behavioral Health Consultant (BHC) placed in medical clinic

Considered a member of the primary care team

Provides consultation (not therapy) Goal of immediate access, minimal barriers Emphasizes psychoeducation, population

mgmt Focus on improving QOL, quality of health

care

30

Page 31: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Part-time IBH coverage

Allowing the BHC “Office Hermit” to go on too long

Clinician’s housed outside of medical providers service delivery area.

Approaching commercial insurance for reimbursement…boomerang effect

Implementing a co-location model

31

Page 32: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

HTN Relaxation skills training, breathing, problem solving

Diabetes Promote goal identification and attainment, enhance mood stability, identify and restructure alarmist thinking, stress reduction

Chronic Pain (multiple presentations), including fibromyalgia syndrome

Promote the use of attention diversion techniques, relaxation skills, stages of pain, values clarification

Obesity Promote goal identification and attainment, behavioral modification, support healthy lifestyle attainment, motivational change, diet/exercise, motivation for change

Medical Diagnosis Behavioral Health Intervention

Page 33: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Better blood sugar control Diminished Missed School Days Diminished rate of patients asked to

leave practice Patient confidence in self-care enhanced Ratio of SM goals set and education

attended enhanced

These goals are important to the patient event if they do not have

a primary care provider

33

Page 34: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

All PCPs reported: Satisfaction with the BHC service Access to BHC as “immediate” and “very

helpful” Better able to address behavioral problems Recommend the service for other medical

providers A majority (> 80%) said because of BHC:

Have greater confidence in how BH issues are treated within the collaborative framework

Able to see more patients in 20 minutes Better recognize patient behavioral issues

34

Page 35: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

90% said visit length “Very Good”, or “Excellent”

88% rated quality of BHC care as “Very Good” or “Excellent”

94% would recommend BHC to family or friends

89% said it was helpful to meet w/ BHC 82% felt BHC involvement resulted in

improved health status

35

Page 36: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

MPHC dismisses 75% fewer patients from our practice since socially embedding a BHC in Internal Medicine

Positive impact on recruitment of medical providers

Broad range of staff training possibilities

36

Page 37: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Thanks for Bill Rosenfeld for providing this information

www.mountainparkhealth.org/

37

Page 38: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

38

Page 39: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

39

Page 40: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Type 1 diabetes is usually diagnosed in children and young adults. The the body does not produce insulin. Only 5% of people with diabetes have this form of the disease.

Type 2 diabetes, the most common form of diabetes, either the body does not produce enough insulin or the cells ignore the insulin. Insulin takes the sugar from the blood into the cells. If insulin is not working, glucose builds up in the blood instead of going into cells, it can lead to diabetes complications. Type 2 diabetes is more common in African Americans, Latinos, Native Americans, Asian Americans, Native Hawaiians and other Pacific Islanders, as well as the aged population.

40

Page 41: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Basic Overview:◦Metabolic disease.◦Hyperglycemia (too much

sugar) due to insulin resistance and defects in insulin secretion.

◦Diabetes can lead to: blindness heart & blood vessel

disease stroke kidney failure amputations nerve damage.

http://safediabetes.blogspot.com/2010/12/how-to-reduce-impact-type-2-diabete.html

41

Page 42: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Often no symptoms at all. Most common symptoms

include:◦ Blurred vision◦ Erectile dysfunction◦ Fatigue◦ Frequent or slow-healing

infections◦ Increased appetite◦ Increased thirst◦ Increased urination

http://www.thetype2diabetesdiet.com/wp-content/uploads/2009/03/symptoms-for-type-2-diabetes.gif

42

Page 43: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Gender* Age* Ethnicity**

*American Diabetes Association, 2011. **US DHHS Office of Minority Health, 2010

43

Page 44: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The hemoglobin A1c test is used to determine how diabetes is being controlled.

HbA1c provides an average of your blood sugar control over a six to 12 week period.

When blood sugar is too high, sugar builds up in your blood and combines with your hemoglobin, becoming "glycated."

For people without diabetes, the normal range for the HbA1c test is 4% - 6%. The goal for people with diabetes is an hemoglobin A1c less than 7%.

Retest should occur every three months to determine level of control.

44

Page 45: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The Medical Provider The Substance Use Disorders Provider The Mental Health Provider Peers and Family

45

Page 46: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Relationship with SUD◦Heavy alcohol consumption can increase risk

factors including: body-mass index, low HDL (“good”) cholesterol and cigarette smoking (Tsumura, 1999).

◦ A history of substance use is associated with earlier age of onset of diabetes (Johnson, 2001).

◦ SUD is associated with increased mortality in diabetics (Jackson, 2007).

Significance of Behavioral Health ◦ Diabetes patients also have increased depression.

Both diet control and depression respond to behavioral activation strategies

◦ In 2006, it was the seventh leading cause of death, and cost the US $174 billion in medical costs, loss of productivity, disability costs

46

Page 47: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Medical services available on-site better link clients in SUD treatment to medical services compared to those with outside referrals (Friedmann, 1999).

Social support for abstinence can increase linkage to medical services. (Saitz, 2004).

Encourage activities that improve diabetes:◦ Better diet.◦ Reduce simple carbohydrate intake (i.e.

potatoes, white bread, corn, soda, candy, sweets). ◦ More exercise.◦ Maintain regular appointments with doctor

overseeing diabetes treatment.

47

Page 48: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Common Medical Issues Associated with Mental Health and Substance Use Disorders

48

Page 49: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

31% 30%

41%

67%

30%

42%

10%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%M

ale

Fem

ale

20-4

4

45-6

4

65-7

4

75+

NH

Whi

te

NH

Bla

ck

Mex

ican

28%

77%

Gender* Ethnicity*

*Centers for Disease Control and Prevention, 2012.

Age*49

Page 50: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Blood pressure (BP) is the force against the walls of one’s arteries while blood is pumping.

Hypertension is when BP is too high.

Example BP: 120/80 mmHg (“120 over 80”)◦ Systolic (top number):

pressure while heart contracts. Normal is <120. High is >180.

◦ Diastolic (bottom number) pressure while heart relaxes & enlarges. Normal is <80. High is >80.

50

Page 51: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Increased risk of:◦Stroke◦Blood vessel damage (arteriosclerosis)

◦Heart attack◦Tearing of heart’s inner wall (aortic dissection)

◦Vision loss◦Brian damage

(NIH, 2010)51

Page 52: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Three or more drinks per day increases BP & risk of hypertension in both women and men (Sesso, 2008).

Decreasing alcohol consumption associated with dose-dependent reduction in BP (Xin, 2001).

Stimulants like cocaine or amphetamines can cause HTN and other acute and chronic cardiovascular diseases. (McMahon,

2010). HTN risk associated with quantity of

cigarettes smoked daily and the duration of smoking (Orth, 2004).◦ Former smokers have higher rates of

hypertension than those who never smoked (Orth, 2004). 52

Page 53: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

HTN can be well controlled in primary care for most patients (Williams 2004).◦ Some many need help finding transportation. ◦ Some may need help finding free or low-cost

clinics. Ask about alcohol consumption. Encourage

limiting to 2 or less drinks per day. If client smokes, give advice and support to

quit smoking (NICE, 2006). Encourage weight loss and salt reduction.

◦ Losing 10kg (22 lbs) can reduce systolic BP by 10 points (Cappuccio, 2007).

53

Page 54: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Common Medical Issues Associated with Mental Health and

Substance Use Disorders

54

Page 55: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

In 2011, at least 100 million adult Americans have common chronic pain conditions (excl. acute pain and children)*.

Pain costs society at least $560-$635 billion annually (an amount equal to about $2,000 for everyone living in the U.S.)*.

Women are more likely to experience pain (in the form of migraines, neck pain, lower back pain, or face or jaw pain) than men**.

Adults age 45-64 years were most likely to report pain lasting more than 24 hrs. (30%), followed by young adults age 20-44 (25%0, and adults age 65 and over (21%)***.

*IOM, 2011; CDC, 2009; NCHS, 2006. 55

Page 56: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

http://www.rxreform.org/wp-content/uploads/2011/06/Toblin-2011-Kansas-Pain-corrected-proof.pdf

Condition Number of Sufferers Source

Chronic Pain 100 million Americans Institute of Medicine of The National Academies

Diabetes 25.8 million Americans(diagnosed and estimated undiagnosed)

American Diabetes Association

Coronary Heart Disease(heart attack and chest pain)

Stroke

16.3 million Americans

7.0 million Americans

American Heart Association

Cancer 11.9 million Americans American Cancer Society

56

Page 57: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Any prescription drug can be “misused” Misuse = “non-medical use” = Any use that is

outside of medically prescribed regimen:◦ Non-compliance ◦ Taking different dose◦ Sharing◦ Obtaining from non-medical source◦ Taking for psychoactive effects◦ Taking for effects not indicated ◦ Use with alcohol or other substances

57

Page 58: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

• Relieves pain• Relieves suffering• Relieves misery

• Makes you feel better • Makes you feel good• Makes you “high”

58

Page 59: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Broad availability of prescription drugs ◦e.g., via the medicine cabinet, family,

friends, Internet, and physicians Misperceptions about their safety Focus on a pill for every ill (cultural trend,

media) High rates of other substance use including

abuse cigarettes, drugs and alcohol Childhood history of abuse, trauma and

neglect High rates of depression and anxiety

59

Page 60: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Pain: An unpleasant sensory and emotional experience arising from the actual or potential tissue damage or described in terms of such damage

It is always subjective. Each individual learns the application of the word through experiences related to injury in early life (International Association for the Study Pain [IASP])

Early life – historicalExperience—learnedSubjective—privateIndividual--unique

60

Page 61: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

65% of patients with depression experience pain

5% to 85% of patients with pain have depression

75% of primary care patients with depression present only with physical complaints and do not attribute their pain to depression

0 or 1 physical symptom - 2% were found to have depression

≥ 9 physical symptoms – 60% were depressed

Increasing pain severity, frequent pain episodes, diffuse pain, and treatment resistant pain are associated with more severe depression

In patients with pain, depression is associated with more pain complaints, greater intensity, longer duration of and greater likelihood of nonrecovery

Bair MJ et al, ARCH INTERN MED, 2003 61

Page 62: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Trends in opioid prescribing (2000 and 2005) with and without MH and SUDs

Insured 34.9% with an MH or SUD 27.8% without MH and SUD

Arkansas Medicaid 55.4% with an MH or SUD 39.8% without an MH or SUD

Insured AR Medicaid62

Page 63: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Chronic use of prescription opioids for NCPC is much higher and growing faster in patients with MH and SUDs than in those without these diagnoses

Clinicians should monitor the use of prescription opioids in these vulnerable groups to determine whether opioids are substituting for or interfering with appropriate MH and substance abuse treatment

Edlund, Mark et al, Clinical Journal of Pain 2010

63

Page 64: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Kowalski & Bondmass (2008) study of pain and grief correlation in widows

Self-reported physical symptoms included:◦ Pain◦ Gastro-intestinal

problems◦ Medical/surgical

conditions◦ Sleep disturbances◦ Neurological/circulatory

issues Psychological

symptoms:◦ Depression◦ Anxiety◦ Loneliness

Of the 173 women in the sample, about two-thirds the sample reported at least one physical complaint following spousal loss

Kowalski & Bondmass, 2008

64

Page 65: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The Dilemma Need to accurately diagnose disease and

provide effective analgesia Some illnesses have no diagnostic test, but

are frequently cited as reasons for pain syndromes needing medication treatment(s) Headache Low back pain Pelvic pain Arthritis Fibromyalgia Chronic Fatigue Syndrome

Has contributed to misuse of pain pills and addiction

65

Page 66: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Predictive factors; as non-pain patients◦Personal or family history of drug abuse

◦Current addiction to alcohol or cigarettes

◦History of problems with prescriptions

◦Co-morbid psychiatric disorders

66

Page 67: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

No validated diagnostic criteria for addiction in pain patients; only “at risk” behaviors: ◦Control◦Compulsive use◦Continue use despite harm◦Craving

Identifying “at risk” patients:◦ History◦ Screening instruments ◦ Behavioral checklists◦ Therapeutic maneuver

67

Page 68: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Mark each box that applies: Female Male

1. Family history of substance abuse

Alcohol 1 3

Illegal drugs 2 3

Prescription drugs 4 4

2. Personal history of substance abuse

Alcohol 3 3

Illegal drugs 4 4

Prescription drugs 5 5

3. Age (mark box if between 16-45 years) 1 1

4. History of preadolescent sexual abuse 3 0

5. Psychological disease

ADO, OCD, bipolar, schizophrenia 2 2

Depression 1 1

Scoring totals:

Scoring

• 0-3: low risk (6%)

• 4-7: moderate risk (28%)

• > 8: high risk (> 90%)

Administration

• On initial visit

• Prior to opioid therapy

Webster, et al. Pain Med. 2005;6:432. 68

Page 69: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Probably more predictive• Selling prescription drugs• Prescription forgery• Stealing or borrowing

another patient’s drugs• Injecting oral formulation• Obtaining prescription drugs

from non-medical sources• Concurrent abuse of related

illicit drugs• Multiple unsanctioned dose

⇧s• Recurrent prescription losses

Passik and Portenoy, 1998 69

Page 70: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Probably more predictive• Selling prescription drugs• Prescription forgery• Stealing or borrowing

another patient’s drugs• Injecting oral formulation• Obtaining prescription drugs

from non-medical sources• Concurrent abuse of related

illicit drugs• Multiple unsanctioned dose

⇧s• Recurrent prescription losses

Probably less predictive• Aggressive complaining

about need for higher dose• Med hoarding when

symptoms are reduced• Requesting specific meds• Acquisition of similar meds

from other medical sources• 1-2 unsanctioned dose ⇧• Unapproved use of the

med for another symptom• Reporting psychic effects

not intended by the clinician

Passik and Portenoy, 1998 70

Page 71: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

71

“Luz” A client from EXODUS ICM

Page 72: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Cl is a 55year old Hispanic (Puerto Rican) female, divorced, mother of 5 adult children, 4 sons and a daughter who passed away 6 yrs ago. Currently estranged from all family members except for one son. Currently renting a bedroom in a home. Cl receives recently was awarded SSI and Medi-Cal benefits. Enrolled in the ICM program September 2012.

72

Page 73: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Presenting problems Initially presented to clinic with sx of depression, anxiety,

crying spells, labile moods, angry outbursts, hopelessness and restless sleep.

Reports she has been depressed most of her life but depression exacerbated 6 yrs ago after the death of her daughter in an MVA. She has extensive drug abuse hx. Drugs of choice are crack and ETOH. Client recently graduated from a residential treatment program and has been sober for 3 yrs.

In January 2013, client exhibited hypomania and delusions that she is pregnant. Presented with elevated mood, decreased need for sleep, racing thoughts, increase in goal directed bx, auditory and visual hallucinations, heavy make-up and poor hygiene. Her diagnosis was noted as Bipolar D/O.

73

Page 74: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

History Client born in Puerto Rico. She has a 3rd grade education

but is illiterate. Speaks Spanish and English. Reports hx of severe physical and sexual abuse at the hands of her father beginning at age 8. Children have been removed form her custody due to drugs and domestic violence with her boyfriend. Family hx of addictions and depression.

Client has no work history other than “selling drugs” and “prostitution”.

Psychiatric history Client was referred by her rehab program to Exodus Urgent

Care Center and then to Exodus ICM . She has previously received brief crisis based services.

74

Page 75: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Medical history: Client has Type 2 Diabetes, hypertension, COPD, and

obesity. At intake, her BP was 139/82, BMI 44.79, Hemoglobin A1C 8.2, smoking 1 pack of cigarettes a day.

Most recent values are as follows: BP 112/75, BMI 41.56, Hemoglobin A1C 5.8, smoking 3-4 cigarettes a day.

Laboratory Normal Values: BP:

◦ Normal systolic is <120. High is >180.◦ Normal diastolic is <80. High is >80.

HbA1c:◦ Normal 4% - 6%. The goal for people with diabetes is an hemoglobin A1c less than

7%.

BMI: ◦ Underweight = <18.5◦ Normal weight = 18.5–24.9◦ Overweight = 25–29.9◦ Obesity = BMI of 30 or greater

75

Page 76: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Diagnosis Axis I 296.44 Bipolar D/O, Manic w/ Psychotic features.

304.80 Polysubstance Dependence in full sustained remission. Axis II No Diagnosis Axis III Type 2 Diabetes, hypertension, hyperlipidemia, COPD, and obesityAxis IV Problems with primary support group, social environment, educational, occupational, economic, access to health care, legal, otherAxis V GAF 55

Medications Lithium 600mg QHS (mood stablizer)

Celexa 20mg QAM (depression)Abilify 2mg QAM (adjunctive tx for for bipolar disorder) 76

Page 77: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Stages of Change:Primary Tasks in Linking

MH and SU

1. PrecontemplationDefinition:

Not yet considering change or is unwilling or unable to change.

Primary Task:Raising Awareness—Connect

SU and MH Sxs2. Contemplation

Definition: Sees the possibility of change but

is ambivalent and uncertain.

Primary Task:Resolving ambivalence/

Helping to choose change

3. DeterminationDefinition:

Committed to changing.Still considering what to do.

Primary Task:Help identify appropriate strategies to improve MH/

reduce SU4. ActionDefinition:

Taking steps toward change but hasn’t stabilized in the process.

Primary Task:Help implement change strategies

to decrease MH Sxs and SU

5. MaintenanceDefinition:

Has achieved the goals and is working to maintain change.

Primary Task:Develop new skills to maintain

improvements in MH and SU

6. RecurrenceDefinition:

Experienced a recurrence of the symptoms.

Primary Task:Cope with consequences , relate to

MH functioning as precursorand outcome

Page 78: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Stages of Change: Intervention Matching Guide to Link MH and SU

• Offer factual information about MH-SU connection

• Explore the events that brought them to treatment—Impact of SU/MH

• Explore results of previous efforts to improve MH. What was the role of SU?

• Explore pros and cons of improving MH and decreasing SU

• Explore the person’s sense of self-efficacy to reduce MH symptoms

• Explore expectations about change—What is the role of SU on MH Sxs?

• Summarize self-motivational statements for change in MH and SU

• Continue exploration of pros and cons of improving MH and decreasing SU

• Offer menu of options for addressing MH Sxs and SU

• Help identify pros and cons of various change options

• Identify and lower barriers to change• Help enlist social/peer support • Encourage person to publicly

announce plans to change

• Support a realistic view of change through small steps

• Identify high-risk situations for SU and impact of use on MH functioning

• Develop coping strategies• Assist in finding new reinforcers of

positive change including feeling better• Help access family/social/peer support

• Help identify and try supportive behaviors and drug-free activities to maintain goals.

• Maintain supportive contact and highlight progress in maintaining improved functioning--What was the role of SU?

• Set new short and long term goals for MH and SU

• Frame recurrence as a learning opportunity—What was the impact on MH?

• Explore possible psychological, behavioral and social antecedents

• Help to develop alternative coping strategies for strong emotions

• Encourage person to stay in the process and maintain support

1. Pre-contemplation

2.Contemplation

3.Determination

4.Action

5.Maintenance

6.Recurrence

Page 79: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Substance use◦ Maintenance of abstinence◦ Supportive behaviors and drug-free activities◦ Maintain supportive contact◦ Set new short and long term goals for MH and SU

Diabetes◦ Blood sugar monitoring and control◦ Identify and support dietary changes.◦ Promote self mgt. ◦ Enhance mood stability◦ Stress Reduction

Page 80: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Obesity◦ Monitoring food/diet◦ Goal identification and attainment◦ Exercise goal identification and tracking

COPD◦ Identifying Triggers◦ Smoking cessation (medical and behavioral)◦ Medication compliance ◦ Daily Monitoring, Action Planning

Social support◦ Identify drug free activities including 12-step, church,

and recreation

Page 81: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Cl was initially identified primarily as depressed and aggressive with people. Client only sought treatment at the request of her rehab program. When she graduated from rehab program, she became homeless. Program assisted her with renting a room.

Client was encouraged to participate in Lunch & Learn, Diabetes Support, Self Help and Seeking Safety groups.

She began making better food choices, reduced her smoking and began walking daily. She lost 17 lbs and has been abstinent from drugs for over 3 yrs.

Cl generally complies with meds and all medical and mental health appointments. She engages in groups 3-4 days/wk, goes to 12 step meetings, and participates in community activities offered by the program. She arrives at the clinic early, is good at seeking support, resources and referrals, and always follows through.

81

Page 82: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

The Warm Hand-Off

82

Page 83: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

• Approximately 5% of patients screened will require referral to substance use evaluation and treatment.

• A patient may be appropriate for referral when:• Assessment of the patient’s responses to the

screening reveals serious medical, social, legal, or interpersonal consequences associated with their substance use.

These high risk patients will receive a brief intervention followed by referral.

83

Page 84: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

• Describe treatment options to patients based on available services

• Develop relationships between health centers, who do screening, and local treatment centers

• Facilitate hand-off by:

• Calling to make appointment for patient/student

• Providing directions and clinic hours to patient/student

• Coordinating transportation when needed

84

Page 85: Thomas E. Freese, PhD Sherry Larkins, PhD UCLA Integrated Substance Abuse Programs Pacific Southwest Addiction Technology Transfer Center 1.

Thomas E. Freese, [email protected]

Sherry Larkins, [email protected]

Pacific Southwest Addiction Technology Transfer CenterUCLA Integrated Substance Abuse Programs

www.psattc.org www.uclaisap.org

85